wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q41876223-B20A0329-41E9-430C-A539-0CFBE7E7C377
Q41876223-B20A0329-41E9-430C-A539-0CFBE7E7C377
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41876223-B20A0329-41E9-430C-A539-0CFBE7E7C377
A survey of inclusion of the time element when reporting adverse effects in randomised controlled trials of cyclo-oxygenase-2 and tumour necrosis factor alpha inhibitors
P2860
Q41876223-B20A0329-41E9-430C-A539-0CFBE7E7C377
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41876223-B20A0329-41E9-430C-A539-0CFBE7E7C377
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6c308aa17de61faf23bbea6fc4354482db086f84
P2860
Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug.